[go: up one dir, main page]

NO891691L - Rekombinant gag-forloeper for hiv. - Google Patents

Rekombinant gag-forloeper for hiv.

Info

Publication number
NO891691L
NO891691L NO89891691A NO891691A NO891691L NO 891691 L NO891691 L NO 891691L NO 89891691 A NO89891691 A NO 89891691A NO 891691 A NO891691 A NO 891691A NO 891691 L NO891691 L NO 891691L
Authority
NO
Norway
Prior art keywords
gag precursor
gag
yeast
precursor
recombinant
Prior art date
Application number
NO89891691A
Other languages
English (en)
Norwegian (no)
Other versions
NO891691D0 (no
Inventor
George P Vlasuk
Mark A Polokoff
Richard A F Dixon
Kathryn J Hofmann
Loren D Schultz
Melvin Silberklang
Ronald W Ellis
Emilio A Emini
Robert J Gerety
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO891691D0 publication Critical patent/NO891691D0/no
Publication of NO891691L publication Critical patent/NO891691L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO89891691A 1988-04-25 1989-04-24 Rekombinant gag-forloeper for hiv. NO891691L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US18562688A 1988-04-25 1988-04-25
US18571188A 1988-04-25 1988-04-25
US18557288A 1988-04-25 1988-04-25
US28214488A 1988-12-09 1988-12-09
US28214588A 1988-12-09 1988-12-09
US28214688A 1988-12-09 1988-12-09

Publications (2)

Publication Number Publication Date
NO891691D0 NO891691D0 (no) 1989-04-24
NO891691L true NO891691L (no) 1989-10-26

Family

ID=27558760

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89891691A NO891691L (no) 1988-04-25 1989-04-24 Rekombinant gag-forloeper for hiv.

Country Status (8)

Country Link
EP (1) EP0340837A1 (da)
JP (1) JPH0213391A (da)
AU (1) AU3335689A (da)
DK (1) DK192389A (da)
FI (1) FI891917A7 (da)
IL (1) IL90048A0 (da)
NO (1) NO891691L (da)
PT (1) PT90354A (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP129A (en) * 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
ATE199394T1 (de) * 1992-06-04 2001-03-15 Univ Osaka Res Found Gag-env fusion-antigen aus hiv
US7556814B2 (en) * 2003-10-23 2009-07-07 Karp Nelson M Immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) devoid of CD55 and CD59 in the viral membrane
US9422342B2 (en) 2006-07-13 2016-08-23 Institute Of Advanced Study Recoding method that removes inhibitory sequences and improves HIV gene expression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO870027L (no) * 1986-01-06 1987-07-07 Hoffmann La Roche Ekspresjon av htlv-iii gag-gen.
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
IL84154A0 (en) * 1986-10-16 1988-03-31 Microgenesys Inc Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same

Also Published As

Publication number Publication date
DK192389D0 (da) 1989-04-20
JPH0213391A (ja) 1990-01-17
PT90354A (pt) 1989-11-10
DK192389A (da) 1989-10-26
FI891917L (fi) 1989-10-26
FI891917A7 (fi) 1989-10-26
NO891691D0 (no) 1989-04-24
IL90048A0 (en) 1989-12-15
EP0340837A1 (en) 1989-11-08
AU3335689A (en) 1989-11-23
FI891917A0 (fi) 1989-04-21

Similar Documents

Publication Publication Date Title
US6140059A (en) Methods for the obtention of human immunodeficiency virsus Type 1 envelope glycoproteins in native and oligomeric form employing recombinant chimeric antigens containing collagenase recognition sites.
Henderson et al. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences
Henderson et al. Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne)
CA1340896C (en) Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
DK174910B1 (da) Antigen, fremgangsmåde til fremstilling af antigenet, fremgangsmåde til diagnosticering samt immunogene præparater
Hansen et al. Characterization of a transpositionally active Ty3 element and identification of the Ty3 integrase protein
US5795577A (en) Viral vector coding for a glycoprotein of the virus responsible for A.I.D.S.
JP2023529432A (ja) 新型コロナウイルス感染症の経口ワクチン及びその調製と応用
NO328824B1 (no) Vaksinesammensetninger som omfatter fusjonsproteiner av HIV-1 NEF-proteiner, fremgangsmate for fremstilling av vaksinesammensetning og protein samt nukleinsyre, proteiner og vert.
NO300462B1 (no) Monoklonale antistoffer og peptider som kan anvendes til diagnose av HIV-infeksjoner
AU604696B2 (en) Viral vector coding for a glycoprotein of the virus responsible for a.i.d.s., vaccine and antibody
NO171477B (no) Immunokjemisk reagens, syntetisk polypeptid, rekombinant dna og plasmid for fremstilling derav, vertscelle transformert med sistnevnte, og proevesett for immunologisk maaling
US5081226A (en) Synthetic peptides sharing sequence homology with the HIV envelope protein
Morikawa HIV capsid assembly
JPH05505616A (ja) 天然のコンホメーションを保持している精製ｇｐ１２０組成物
AU596154B2 (en) Fusion proteins
NO891691L (no) Rekombinant gag-forloeper for hiv.
WO1989012095A1 (en) A method of evaluating recombinant vaccines against immunodeficiency virus
WO1998041536A9 (en) Glycosylation deficient siv and hiv envelope glycoproteins
US20060281075A1 (en) Purification of viruses, proteins and nucleic acids
WO2005010033A1 (en) New soluble and stabilized trimeric form of gp41 polypeptides
EP0421626A1 (en) Vaccine for aids and hepatitis B
AU604791B2 (en) Viral vector and recombinant DNA coding, in particular, for the p25 protein of the virus that is a causal agent of aids, infected cell culture, protein obtained, vaccine and antibodies obtained
EP0322394A2 (en) Expression of HIV proteins in E. coli and S. cerevisiae
WO2022006095A2 (en) Mosaic hiv-1 envelopes to induce adcc responses